Gamma-glutamyl transferase-to-lymphocyte ratio as a prognostic marker in patients with hepatocellular carcinoma undergoing hepatectomy

Figure 1 Schoenfeld residual plots. A: Gamma-glutamyl transferase-to-lymphocyte ratio (GLR); B: Sex; C: Degree of differentiation; D: Microvascular invasion (MVI).

Figure 2 Receiver operating characteristic analysis of gamma-glutamyl transferase-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and neutrophil-to-lymphocyte ratio. Area under the curve (AUC) for overall survival was 0.775, 0.601, and 0.539 for gamma-glutamyl transferase-to-lymphocyte ratio (GLR), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR). ROC: Receiver operating characteristic.

Figure 3 Kaplan-Meier survival curves for overall survival based on gamma-glutamyl transferase-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma. A: Kaplan-Meier curve for overall survival (OS) based on low and high gamma-glutamyl transferase-to-lymphocyte ratio (GLR) groups; B: Kaplan-Meier curve for OS based on low and high neutrophil-to-lymphocyte ratio (NLR) groups; C: Kaplan-Meier curve for OS based on low and high platelet-to-lymphocyte (PLR) ratio groups.

Figure 4 Nomogram for predicting overall survival of patients with hepatocellular carcinoma after curative resection. GLR: Gamma-glutamyl transferase-to-lymphocyte ratio; MVI: Microvascular invasion; PLR: Platelet-to-lymphocyte ratio; TACE: Transarterial chemoembolization; TBIL: Total bilirubin.

Figure 5 Calibration curve of the prognostic nomogram for overall survival in patients with hepatocellular carcinoma. The 1-year overall survival (OS) prediction from the nomogram compared with the actual 1-year OS.